Neutralizing antibody levels associated with injectable and aerosolized Ad5-nCoV boosters and BA.2 infection

BACKGROUND: Several COVID-19 vaccines are in widespread use in China. Few data exist on comparative immunogenicity of different COVID-19 vaccines given as booster doses. We aimed to assess neutralizing antibody levels raised by injectable and inhaled aerosolized recombinant adenovirus type 5 (Ad5)-v...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fuzhen, Huang, Baoying, Deng, Yao, Zhang, Shaobai, Liu, Xiaoqiang, Wang, Lei, Liu, Qianqian, Zhao, Li, Tang, Lin, Wang, Wenling, Wang, Xiaoqi, Ye, Fei, Hu, Weijun, Yang, Haitao, Wang, Siquan, Ren, Jiao, Liu, Xiaoyu, Wang, Cangning, Guan, Xuhua, Wang, Ruize, Zheng, Yan, Zhang, Xianfeng, Zheng, Hui, Wu, Dan, An, Zhijie, Xu, Wenbo, Rodewald, Lawrence E., Gao, George F., Yin, Zundong, Tan, Wenjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318644/
https://www.ncbi.nlm.nih.gov/pubmed/37400857
http://dx.doi.org/10.1186/s12916-023-02942-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318644/
https://www.ncbi.nlm.nih.gov/pubmed/37400857
http://dx.doi.org/10.1186/s12916-023-02942-3

Ejemplares similares